Schroder Investment Management Group grew its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 5.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 420,798 shares of the medical equipment provider's stock after buying an additional 23,426 shares during the quarter. Schroder Investment Management Group owned 0.12% of Intuitive Surgical worth $219,640,000 as of its most recent SEC filing.
Other institutional investors have also recently added to or reduced their stakes in the company. Bennett Selby Investments LP grew its holdings in shares of Intuitive Surgical by 3.9% during the 4th quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider's stock worth $234,000 after purchasing an additional 17 shares in the last quarter. Onefund LLC lifted its position in Intuitive Surgical by 1.9% in the fourth quarter. Onefund LLC now owns 947 shares of the medical equipment provider's stock worth $494,000 after purchasing an additional 18 shares during the period. LVW Advisors LLC boosted its stake in Intuitive Surgical by 1.3% during the fourth quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider's stock worth $756,000 after buying an additional 19 shares in the last quarter. Wesbanco Bank Inc. increased its holdings in Intuitive Surgical by 1.6% in the 4th quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider's stock valued at $635,000 after buying an additional 19 shares during the period. Finally, Journey Strategic Wealth LLC raised its stake in shares of Intuitive Surgical by 1.9% in the 4th quarter. Journey Strategic Wealth LLC now owns 1,039 shares of the medical equipment provider's stock valued at $542,000 after buying an additional 19 shares in the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.
Intuitive Surgical Trading Up 0.2 %
Shares of Intuitive Surgical stock traded up $1.09 during trading on Tuesday, reaching $496.36. The stock had a trading volume of 1,609,268 shares, compared to its average volume of 1,530,403. The stock has a fifty day moving average price of $554.33 and a two-hundred day moving average price of $532.98. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00. The company has a market capitalization of $176.79 billion, a price-to-earnings ratio of 77.44, a P/E/G ratio of 5.85 and a beta of 1.43.
Analysts Set New Price Targets
Several research analysts recently issued reports on ISRG shares. UBS Group increased their price target on shares of Intuitive Surgical from $500.00 to $560.00 and gave the stock a "neutral" rating in a research report on Monday, January 27th. Leerink Partners boosted their price target on Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. Barclays increased their price objective on Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. CICC Research started coverage on shares of Intuitive Surgical in a report on Monday, January 27th. They issued a "neutral" rating and a $550.00 target price on the stock. Finally, JPMorgan Chase & Co. lifted their price target on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an "overweight" rating in a report on Friday, January 24th. One analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical presently has an average rating of "Moderate Buy" and an average target price of $611.86.
Read Our Latest Stock Report on ISRG
Insider Buying and Selling at Intuitive Surgical
In other Intuitive Surgical news, VP Fredrik Widman sold 810 shares of the firm's stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $573.78, for a total transaction of $464,761.80. Following the completion of the sale, the vice president now owns 473 shares of the company's stock, valued at $271,397.94. This trade represents a 63.13 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Robert Desantis sold 11,545 shares of the company's stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the completion of the transaction, the executive vice president now owns 5,224 shares in the company, valued at approximately $2,607,925.28. This represents a 68.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 33,754 shares of company stock worth $17,691,621 over the last ninety days. 0.70% of the stock is currently owned by corporate insiders.
Intuitive Surgical Profile
(
Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Further Reading

Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.